Top News

Thermo Fisher Scientific to Acquire Brammer Bio

March 25, 2019

A $1.7-billion acquisition CDMO Brammer Bio establishes Thermo Fisher Scientific in viral vector manufacturing.

Novartis Changes Sandoz Leadership, Sandoz CEO Steps Down

March 18, 2019

Richard Francis will step down as CEO of Sandoz, effective March 31, 2019.

Administration Acts Fast to Smooth Transition to New FDA Commissioner

March 13, 2019

Norman (Ned) Sharpless, director of the National Cancer Institute at the National Institutes of Health, will become FDA acting commissioner.

FDA Only Winner as New Budget Battle Begins

March 13, 2019

The FDA planned budget features added funds allotted to improved oversight of drugs, biologics, and medical devices.

NCI Director Named as Acting FDA Commissioner

March 12, 2019

Ned Sharpless is tapped to take on acting commissioner role following Gottlieb’s resignation.

Fujifilm to Acquire Large-Scale Biologics Manufacturing Site from Biogen in $890-Million Deal

March 12, 2019

The acquisition of the site in Copenhagen, Denmark, will significantly expand Fujifilm’s capacity and capabilities.

FDA Takes Steps to Refine Biosimilar Naming Convention

March 08, 2019

FDA Commissioner Gottlieb released a statement on the agency’s efforts to refine the naming convention for biosimilars to balance competition and to help ensure patient safety.

Latest ARB Recall Triggered by New Impurity

March 07, 2019

Hetero Labs recalls losartan potassium tablets due to presence of N-Nitroso-N-methyl-4-aminobutyric acid.

FDA to Miss Gottlieb’s Leadership

March 06, 2019

Gottlieb’s tenure included record new drug approvals and steps taken to curb opioid abuse.

Biogen to Acquire Gene-Therapy Company Nightstar in $800-Million Deal

March 05, 2019

The acquisition will establish a clinical pipeline for Biogen of gene-therapy candidates in ophthalmology.